VIRGINIA RIVERA: Open Payments
NPI 1255032777 · ROCKY HILL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,132 in 82 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $1,057 · 2025 $2,132
Food & beverage: $2,132
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $274 |
| ABBVIE INC. | 5 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $148 |
| Axsome Therapeutics, Inc. | 2 | $135 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Novo Nordisk Inc | 5 | $116 |
| GlaxoSmithKline, LLC. | 5 | $111 |
| Exact Sciences Corporation | 4 | $98 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
Products named: VRAYLAR, BREZTRI, TRINTELLIX, Auvelity, VOQUEZNA, XIFAXAN, AIRSUPRA, MOUNJARO.
Industry payments across CT — which companies pay providers there.
